Jonathan Siegrist
Fortune : 174 715 $ au 31/05/2026
Fortune : 174 715 $ au 31/05/2026
Jonathan Siegrist is currently Chief Technology Officer, Executive VP-R&D at QuidelOrtho Corp.
since 2024.
Formerly, Dr. Siegrist was Chief Technology Officer & Head-Assay Research at CEPHEID.
Education includes undergraduate studies at the University of California, Los Angeles and a doctorate from the University of California, Irvine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/01/2026 | 13 419 ( 0,02% ) | 174 715 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| QUIDELORTHO CORPORATION | Directeur Technique/Scientifique/R&D | 07/10/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| CEPHEID | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
CEPHEID
CEPHEID Medical SpecialtiesHealth Technology Develops, manufactures and markets molecular diagnostic systems | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QuidelOrtho Corp.
QuidelOrtho Corp. Medical SpecialtiesHealth Technology Manufactures in vitro diagnostics products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national